CARR vs ERNA · P/E 43, rev $5.15B vs P/E 0.0, rev $582.0K
Carrier Global Corp (CARR) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CARR and ERNA stock pages for the full models.
Not investment advice.